Enzo Biochem (ENZ) executive Cannon received 87,500 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Kara Cannon (executive at Enzo Biochem Inc., ENZ) reported that they received 87,500 shares on Mar 24, 2022.
- Reporting person
- Cannon Kara
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Mar 24, 2022 | Grant or award (A) | Stock Option (to acquire Common Stock)On 87,500 Common Stock1 | +87,500 | - | - | 87,500 direct |
Holdings before and after
- Stock Option (to acquire Common Stock): 0 to 87,500 direct
Other positions listed
- Common Stock, $0.01 Par Value: 22,614 indirect, 401k
Footnotes from the filing
- 1. The stock options have a five-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Cannon report in this ENZ Form 4?
Kara Cannon (executive at Enzo Biochem Inc., ENZ) reported that they received 87,500 shares on Mar 24, 2022.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for ENZ
Earlier insider filings at ENZ
Quantisnow market dataNYSE
ENZ
Enzo Biochem Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical Specialities
- Listed since
- 1988
Get push alerts for ENZ
Full ENZ profile on Quantisnow Follow ENZ and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time